Exposure to Outdoor Cold Air Beneficial for Children With Croup
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
TUESDAY, Aug. 1, 2023 -- A 30-minute exposure to outdoor cold air is beneficial for reducing clinical symptoms in children with croup as an adjunct to oral dexamethasone, according to a study published online Aug. 1 in Pediatrics.
Johan N. Siebert, M.D., from Geneva Children's Hospital in Switzerland, and colleagues conducted an open-label, single-center, randomized trial enrolling children aged 3 months to 10 years with croup and a Westley Croup Score (WCS) ≥2 attending a tertiary pediatric emergency department. Immediately after triage and administration of single-dose oral dexamethasone, patients were randomly assigned to a 30-minute exposure to outdoor cold (<10 degrees Celsius) atmospheric air or to indoor ambient room air (59 participants in each group).
The researchers found that at 30 minutes, 49.2 and 23.7 percent of the participants in the outdoor and indoor groups, respectively, showed a decrease in WCS ≥2 points from baseline (risk difference, 25.4 percent). The greatest benefit from the intervention at 30 minutes was seen for patients with moderate croup (risk difference, 46.1 percent).
"This randomized controlled trial supports the benefits of exposure to outdoor cold air on croup symptoms in children with mild to moderate croup in the first 30 minutes before the onset of action of steroids," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
American College of Obstetricians and Gynecologists, May 17-19
The annual meeting of the American College of Obstetricians and Gynecologists was held from May 17 to 19 in San Francisco and was attended by more than 4,000 clinicians...
Epidural Analgesia Linked to Decline in Severe Maternal Morbidity
FRIDAY, May 24, 2024 -- Epidural analgesia during labor is associated with a reduction in severe maternal morbidity (SMM), according to a study published online May 22 in The...
Prenatal Exposure to Endocrine-Disrupting Chemicals Affects Child's Metabolic Health
FRIDAY, May 24, 2024 -- Prenatal exposure to endocrine-disrupting chemicals (EDCs) is associated with adverse metabolic health in children, according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.